NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Care Facilities · USD

Fresenius Medical Care AG (FMS) Stock Analysis

Fresenius Medical Care AG (FMS) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.

FMS

$22.66

+$0.19 (+0.85%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare FMS with… →

FMS Key Statistics

As of Sep 4, 2026
Trading
Open
$22.66
Previous Close
$22.47
Day's Range
22.56–22.78
52-Week Range
20.02–27.64
Volume
480.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.83
Valuation
Market Cap
$12.06B
P/E Ratio
11.68
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
6.22
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.72
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.62
EPS (ttm)Profit attributable to each share over the last twelve months.
1.94
Financials (FY)
Revenue (FY)
$19.63B+1.51%
Net Income (FY)
$978.37M+81.88%
Profit marginThe share of revenue left as profit after all costs and taxes.
4.83%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
532.22M
1-Year Return
−3.03%
Dividend and dates
Dividend
$0.87+3.88%
Ex-Dividend Date
May 22, 2026
Earnings Date
November 3, 2026
Avg Volume
669.43K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

FMS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−1.03%
2025+8.22%
2024+11.86%
2023+30.88%
2022−48.42%
2021−20.28%
2020+14.73%
2019+15.62%
2018−37.60%
2017+25.89%
2016 (partial year)−8.14%

As of September 4, 2026.

FMS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$19.63B$978.37M5.0%
2024$19.34B$537.91M2.8%
2023$19.45B$499.00M2.6%
2022$19.40B$673.41M3.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$19.63B$5.03B$1.83B$978.37M5.0%
2024$19.34B$4.76B$1.47B$537.91M2.8%
2023$19.45B$4.93B$1.48B$499.00M2.6%
2022$19.40B$4.89B$1.45B$673.41M3.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

FMS Dividend History

$0.82+28.5% vs 2024

Dividends per share, 2025 · 1 payments

YearDividends per sharePaymentsChange
2026*$0.871—
2025$0.821+28.5%
2024$0.631+2.6%
2023$0.621−12.8%
YearDividends per sharePaymentsChange
2026 (partial year)$0.871—
2025$0.821+28.5%
2024$0.631+2.6%
2023$0.621−12.8%
2022$0.711−15.0%
2021$0.831+18.0%
2020$0.711+7.9%
2019$0.661+3.6%
2018$0.631+23.0%
2017$0.511—

Most recent payment: $0.87 per share, ex-dividend May 22, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

FMS Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricFMSMedical Care Facilities medianvs median
P/E11.6819.8441% below
P/S ratio0.620.9535% below
Profit margin4.83%3.06%1.8 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 9 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Fresenius Medical Care AG (FMS) at $12.06B. The company sits in the Healthcare sector, in the Medical Care Facilities industry. The company reports 107,226 employees.

FMS last closed at $22.66 on September 4, 2026. That is +$0.19 (+0.85%) against the previous close. Over the past 52 weeks the price has ranged from $20.02 to $27.64. The latest close sits 13.19% above that 52-week low.

Financial Health

In fiscal 2025, Fresenius Medical Care AG reported revenue of $19.63B. Against the prior fiscal year total of $19.34B, that is a change of +1.51%. Net income for the same year was $978.37M. That is +81.88% against the prior fiscal year. Profit margin runs at 4.83%. That is 1.8 percentage points above the Medical Care Facilities median of 3.06%. Trailing earnings per share are 1.94.

Across the 4 fiscal years on file, revenue moves from $19.40B in 2022 to $19.63B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

FMS trades at a trailing price-to-earnings ratio of 11.68. That is 41.13% below the Medical Care Facilities median of 19.84. On forward earnings the ratio is 6.22. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.72. Measured against sales, the shares trade at 0.62 times revenue. On price-to-sales that is 34.69% below the Medical Care Facilities median of 0.95. 57 Medical Care Facilities companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.83. Daily returns over the trailing 10 years annualize to a volatility of 29.34%. The trailing one-year price return is −3.03%. Measured over 10 years, that is −4.45% a year compounded.

Growth & Income

The trailing dividend yield is 3.88%. That is 2.4 percentage points above the Medical Care Facilities median yield of 1.51%. The indicated annual rate is $0.87 a share. The ex-dividend date on file is May 22, 2026. Dividends are recorded for 10 calendar years; 2026 shows 1 payments totalling $0.87 a share. The year before, 2025, totalled $0.82 a share.

Across the complete calendar years on file, 2023 returned +30.88% and 2022 returned −48.42%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is −1.03%.

Peer Comparison

Fresenius Medical Care AG (FMS) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Fresenius Medical Care AG FMS $12.06B 11.7
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Encompass Health Corporation EHC $12.01B 20.4

The Medical Care Facilities industry average P/E ratio is 19.8x. Fresenius Medical Care AG trades at a P/E of 11.7.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$87.68B

 THC

Tenet Healthcare Corporation

$21.34B

 EHC

Encompass Health Corporation

$12.01B

 DVA

DaVita Inc.

$11.74B

 UHS

Universal Health Services, Inc.

$10.00B

 ENSG

The Ensign Group, Inc.

$9.95B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Visit website →